Related Experiment Video
Updated: Aug 16, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Structural Cerebral Network Differences in Prodromal Alzheimer's Disease and Prodromal Dementia with Lewy Bodies
Miho Ota1, Kiyotaka Nemoto1, Miyuki Nemoto2
1Division of Clinical Medicine, Department of Psychiatry, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Introduction:
Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) have long prodromal phases without dementia. However, the patterns of cerebral network alteration in this early stage of the disease remain to be clarified.
Method:
Participants were 48 patients with mild cognitive impairment (MCI) due to AD (MCI-AD), 18 patients with MCI with DLB (MCI with Lewy bodies: MCI-LB), and 23 healthy controls who underwent a 1.5-Tesla magnetic resonance imaging scan. Cerebral networks were extracted from individual T1-weighted images based on the intracortical similarity, and we estimated the differences of network metrics among the three diagnostic groups.
Results:
Whole-brain analyses for degree, betweenness centrality, and clustering coefficient images were performed using SPM8 software. The patients with MCI-LB showed significant reduction of degree in right putamen, compared with healthy subjects. The MCI-AD patients showed significant lower degree in left insula and bilateral posterior cingulate cortices compared with healthy subjects. There were no significant differences in small-world properties and in regional gray matter volume among the three groups.
Conclusions:
We found the change of degree in the patients with MCI-AD and with MCI-LB, compared with healthy controls. These findings were consistent with the past single-photon emission computed tomography studies focusing on AD and DLB. The disease-related difference in the cerebral neural network might provide an adjunct biomarker for the early detection of AD and DLB.
Insights
Early Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) show altered brain network degrees in specific regions. These cerebral network changes may help detect AD and DLB early.
Area of Science:
- Neuroscience
- Medical Imaging
- Neurology
Background:
- Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) have extended prodromal stages.
- Cerebral network alterations during these early, pre-dementia phases are not well understood.
Purpose of the Study:
- To investigate and clarify patterns of cerebral network changes in mild cognitive impairment (MCI) associated with AD (MCI-AD) and DLB (MCI-LB).
- To identify potential early biomarkers for AD and DLB based on neural network differences.
Main Methods:
- Magnetic resonance imaging (MRI) was used to analyze cerebral networks in 48 MCI-AD patients, 18 MCI-LB patients, and 23 healthy controls.
- Network metrics, including degree, betweenness centrality, and clustering coefficient, were extracted from T1-weighted images.
- Whole-brain analyses were conducted using SPM8 software.
Main Results:
- MCI-LB patients exhibited reduced degree in the right putamen compared to controls.
- MCI-AD patients showed significantly lower degrees in the left insula and bilateral posterior cingulate cortices versus controls.
- No significant differences were found in small-world properties or regional gray matter volume among the groups.
Conclusions:
- Cerebral network degree alterations were observed in both MCI-AD and MCI-LB patients compared to healthy individuals.
- These findings align with previous studies using single-photon emission computed tomography.
- Disease-related changes in cerebral neural networks could serve as adjunct biomarkers for early AD and DLB detection.
More Related Videos
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neural Regulation
Dementia
The progression of dementia is generally gradual....
Parkinson's Disease: Overview